Skip to main content
. 2017 Mar 20;20(3):143–148. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2017.03.01

1.

1

HARS转染角质细胞移植至免疫同源FVB/N小鼠背部成瘤。A:基因组EGFRflx/flx肿瘤生长较野生基因型组EGFRwt/wt迟缓;B:药理组连续1周系统性喂食吉非替尼小鼠体积较对照组较小。*P<0.05。

Tumors originated from HRAS transformed FVB/N primary keratinocytes grafted on the back of immunocompetent syngeneic mice. A: EGFRflx/flx keratinocytes that formed the malignant squamous tumors are smaller formed from than the EGFRwt/wt; B: Pharmacological blockade of EGFR by systemic administration of gefitinib or 10% DMSO for 1 week, the former tumors are smaller. *P < 0.05.